A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality

PHASE2RecruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

February 28, 2026

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

TQB2102 for injection

HER2 dual-antibody-drug Conjugate (ADC).

DRUG

TQB2102 for injection combined with Benmelstobart injection

TQB2102 for injection is a HER2 dual-antibody-drug Conjugate (ADC); Benmelstobart injection is a humanized monoclonal antibody targeting programmed death ligand-1 (PD-L1).

Trial Locations (25)

53000

NOT_YET_RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

100142

NOT_YET_RECRUITING

Beijing Cancer Hospital, Beijing

130012

NOT_YET_RECRUITING

Jilin Cancer Hospital, Changchun

150081

NOT_YET_RECRUITING

Harbin Medical University cancer hospital, Harbin

200032

NOT_YET_RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

210000

NOT_YET_RECRUITING

Jiangsu Provincial People's Hospital, Nanjing

250117

NOT_YET_RECRUITING

Affiliated Cancer Hospital of Shandong First Medical University, Jinan

300181

NOT_YET_RECRUITING

Tianjin Medical University Cancer Institute&Hpspital, Tianjin

325015

NOT_YET_RECRUITING

The 1th School of Medicine,School of Information and Engineering.The 1th Affiliated Hospital of WMU, Wenzhou

330006

NOT_YET_RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

341099

NOT_YET_RECRUITING

First Affiliated Hospital of Gannan Medical University, Ganzhou

350014

RECRUITING

Fujian Cancer Hospital, Fuzhou

410031

NOT_YET_RECRUITING

Hunan Provincial Tumor Hospital, Changsha

430000

NOT_YET_RECRUITING

Tongji Medical College, Huazhong University of Science and Technology, Wuhan

450000

NOT_YET_RECRUITING

Henan Cancer Hospital, Zhengzhou

510060

NOT_YET_RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

518035

NOT_YET_RECRUITING

The Second People's Hospital of Shenzhen, Shenzhen

528000

NOT_YET_RECRUITING

Foshan First People's Hospital, Foshan

529000

NOT_YET_RECRUITING

Jiangmen Central Hospital, Jiangmen

563006

NOT_YET_RECRUITING

The Second Affiliated Hospital of Zunyi Medical University, Zunyi

610000

NOT_YET_RECRUITING

Sichuan Provincial People's Hospital, Chengdu

610040

NOT_YET_RECRUITING

Sichuan Cancer Hospital, Chengdu

614099

NOT_YET_RECRUITING

Leshan People's Hospital, Leshan

710000

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

830001

NOT_YET_RECRUITING

Xinjiang Uygur Autonomous Region Cancer Hospital, Ürümqi

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

INDUSTRY